Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
MAX-4 by Maxinovel Pharmaceuticals for Solid Tumor: Likelihood of Approval
MAX-4 is under clinical development by Maxinovel Pharmaceuticals and currently in Phase I for Solid Tumor. According to GlobalData, Phase...
MAX-4 by Maxinovel Pharmaceuticals for Relapsed Acute Myeloid Leukemia: Likelihood of Approval
MAX-4 is under clinical development by Maxinovel Pharmaceuticals and currently in Phase II for Relapsed Acute Myeloid Leukemia. According to...
MAX-4 by Maxinovel Pharmaceuticals for Refractory Acute Myeloid Leukemia: Likelihood of Approval
MAX-4 is under clinical development by Maxinovel Pharmaceuticals and currently in Phase II for Refractory Acute Myeloid Leukemia. According to...
MAX-4 by Maxinovel Pharmaceuticals for Myelodysplastic Syndrome: Likelihood of Approval
MAX-4 is under clinical development by Maxinovel Pharmaceuticals and currently in Phase II for Myelodysplastic Syndrome. According to GlobalData, Phase...
MAX-4 by Maxinovel Pharmaceuticals for Metastatic Colorectal Cancer: Likelihood of Approval
MAX-4 is under clinical development by Maxinovel Pharmaceuticals and currently in Phase II for Metastatic Colorectal Cancer. According to GlobalData,...